News | April 25, 2013

Philips Collaborates With Partners to Introduce Advanced MRI Clinical Functionalities

New clinical functionalities designed to transform care in MRI address the challenges of an aging population and economic pressures on health care providers

April 25, 2013 — At the International Society for Magnetic Resonance in Medicine’s (ISMRM) 21st Annual Meeting in Salt Lake City, Utah, Philips Healthcare demonstrated a range of clinical functionalities in magnetic resonance imaging (MRI).

An increasing global incidence of neuro and vascular disease across the world is a result of both aging populations and increasingly unhealthy lifestyles. Philips is working in close collaboration with clinicians and researchers from across the world to develop new clinical functionalities that support high quality, clinically relevant diagnostics, whilst also improving patient throughput.

“Increasingly, MRI is proving its worth as a quick and cost effective diagnostic tool for the management of a wide variety of conditions; from stroke and dementia to tumor disease and trauma,” commented Dr. Jeroen Hendrikse, University Medical Center Utrecht, department of radiology. “A great example of this is pCASL, a functionality we’ve developed in close collaboration with the team at Philips. Not only does pCASL provide the user with an accurate assessment of brain perfusion — without the need for external contrast agent, a contraindication for many patients with renal insufficiency — but it’s also quick, taking just a short amount of additional time to scan.”

Jeffrey Miller, M.D., pediatric neuroradiologist, Phoenix Children’s Hospital, Arizona, adds, “Having access to these functionalities (pCASL, SWIp, mDIXON TSE and mDIXON Quant) means that we’re able to detect injuries that may not be apparent using conventional techniques, which can ultimately mean a better outcome for our patients. In particular, we’re seeing a real benefit from the image quality provided by the time-efficient mDIXON TSE technique in challenging anatomies such as spine, as well as the lesion delineation it provides.”

The functionalities*, developed collaboratively, that are being showcased at ISMRM include:

  • pCASL (pseudo-Continuous Arterial Spin Labeling) — using arterial water as an endogenous tracer, pCASL provides cost effective and accurate assessment of changes in brain perfusion, without the need for contrast agent injection.
  • SWIp** (Susceptibility Weighted Imaging with Phase difference) — utilizing phase information to enhance susceptibility contrast between tissues and a multi-echo acquisition to provide high SNR (signal-to-noise ratio), SWIp can help in the diagnosis of various brain lesions such as hemorrhage or venous malformation.
  • mDIXON TSE — a fast two-point DIXON technique that robustly separates water and fat signals, allowing for time-efficient, large FOV (field-of-view) fat-free imaging even in challenging areas such as head, neck or spine, and providing four contrasts in one scan.
  • mDIXON Quant** — utilizing an mDIXON multi-gradient-echo technique and state-of-the-art reconstruction for fast, volumetric, fat fraction quantification mapping, targeting anatomies such as the liver.

The development of these latest functionalities is a direct result of the ongoing clinical collaborations, which Philips has in-place with leading clinicians and researchers, including with Hendrikse in Utrecht and Miller in Phoenix.

“As we continue to expand our MRI portfolio at Philips, our focus is to provide solutions that address the day-to-day needs of the radiology and clinical teams. Ultimately, innovation is only meaningful if it can bring about positive change for patients. Our commitment to achieving this is evident through our many and ongoing research collaborations,” commented Eric Jean, general manager, global MR, Philips Healthcare. “It really is exciting to see that this approach is instrumental in addressing some of the most significant challenges in MRI today.”

* New functionalities available now on Philips Ingenia system, and on all Philips MRI systems by end of 2013

** 510(k) pending. Not available for sale in USA

For more information: www.philips.com/ismrm

Related Content

AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...